(Q50663539)

17 March 2018

title

Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. (English)

1 reference

17 March 2018

0 references

Pearce LA

1

1 reference

17 March 2018

Hart RG

series ordinal

2

1 reference

17 March 2018

Halperin JL

series ordinal

3

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

17 March 2018

American Journal of Medicine

published in

1 reference

17 March 2018

volume

109

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

45-51

1 reference

17 March 2018

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Stroke risk in an elderly population with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Antithrombotic therapy in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Patients with atrial fibrillation at low risk of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Screening for atrial fibrillation in primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Atrial fibrillation and stroke prevention in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

Risk assessment and anticoagulation for primary stroke prevention in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900440-X

10.1016/S0002-9343(00)00440-X

7 January 2021

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018